BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

NCT04136470 · clinicaltrials.gov ↗

UNKNOWN

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Microbiome
Metagenome
Immunotherapy
Melanoma

Interventions

BIOLOGICAL: Collection of stool, blood (PBMC) and biopsy (FFPE)

Sponsor

Ardigen

Collaborators

[object Object]